Paris-based drugmaker Sanofi had revenue of $8.4 billion from Lantus last year. It lost U.S. patent protection this month and will lose exclusive rights in Europe in May.
Although the experimental diabetes drug is in final-stage testing and showing promising results, Lilly wants to better understand its effect on liver fat.
Nearly eight years after announcing the closure of its Beech Grove campus, Franciscan St. Francis Health has two serious suitors for the 14-acre property. Los Angeles-based DealPoint Merrill signed an agreement months ago for $3.75 million, including transaction costs. DealPoint plans to fill the 869,000 square feet of rentable space with medical tenants. But closing […]
The U.S. Department of Justice told Lilly last month its investigation was over—more than a year after the drugmaker paid $29 million to the SEC to settle related bribery allegations.
Bloomington-based CarDon & Associates Inc. is facing opposition to its plan to rezone more than 25 acres to build a senior living campus in Zionsville. Residents from neighborhoods near the proposed campus packed Town Hall on Jan. 20 to voice their opposition to the project, which they say will cause traffic problems and is too […]
Takeda Pharmaceutical Co. was ordered by a jury Thursday to pay more than $2.3 million in damages to a former teacher who blamed the company’s Actos diabetes drug for causing his bladder cancer.
Visit Indy in the last six months has signed deals for four sizable medical/pharmaceutical-related conventions—hard-earned wins for a city that for years has aimed to be a biomedical hub that attracts big players for annual gatherings.
A three-year moratorium on construction of new nursing home beds sailed through the Indiana Senate 35-14 on Feb. 3. Senate Bill 460 now moves to the House, where it will be sponsored by Rep. Tim Brown, R-Crawfordsville, the powerful chairman of the Ways and Means Committee, and Rep. Charlie Brown, D-Gary. The moratorium moved easily […]
The Indiana Office of Utility Consumer Counselor is inviting written comments from Indianapolis Power & Light customers about the utility’s pending request to raise electricity prices.
Announcements Community Solutions Inc., an Indianapolis-based human service and community development-consulting firm, is accepting applications for their 2015 Pro Bono client. Applicants must come from 501(c) (3) community-based organizations with agency budgets under $500,000 that have been operational for at least three years. The selected client will receive 120 hours of free services provided over a […]
A Cuban immigrant was sentenced Wednesday to more than six years in prison for his role in the 2010 heist of a Connecticut warehouse in which the robbers filled a tractor-trailer with more than $50 million worth of Eli Lilly and Co. pharmaceuticals.
More medical malpractice cases could be filed directly in state trial courts without first having to go through the mandatory medical review process, under legislation pending in the Indiana Senate. Senate Bill 55, which cleared the Senate Judiciary Committee Jan. 21, raises the dollar amount of malpractice claims exempt from the medical review panel process […]
Eli Lilly and Co. predicted its 2015 sales will come in roughly $1 billion less than analysts have expected, due to the strength of the U.S. dollar against foreign currencies.
Indiana won’t put itself on the marijuana-friendly map this year, as a medical marijuana bill authored by Democratic Sen. Karen Tallian is unlikely to go further than a committee hearing.
Jason Riley, 34, director of human resources and global talent development at Hillenbrand Inc., embraced his company’s global outlook as a talent-development tool.
Novartis AG is racing to establish itself in the market for new treatments for psoriasis ahead of competing drugs by Amgen Inc. and Eli Lilly and Co. in the United States.
The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they’re broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
